Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 34, 2020 - Issue 24
261
Views
6
CrossRef citations to date
0
Altmetric
Short Communications

Phytochemistry and antiplasmodial activity of Xylopia sericea leaves

ORCID Icon, , & ORCID Icon
Pages 3526-3530 | Received 10 Dec 2018, Accepted 26 Jan 2019, Published online: 27 Feb 2019
 

Abstract

Aiming to investigate the antiplasmodial activity and the phytochemical composition of Xylopia sericea leaves, the essential oil and dichloromethane extract were analyzed by gas and liquid chromatography, respectively, both of them coupled to mass spectrometry, and were evaluated against the chloroquine-resistant Plasmodium falciparum strain (W2) and for cytotoxicity to HepG2 cells. Low growth inhibition of P. falciparum as well as low cytotoxicity to HepG2 cells were observed for the essential oil. The leaves dichloromethane extract showed moderate growth inhibition of P. falciparum and low cytotoxicity to HepG2 cells. Bioguided chromatographic fractionation of this extract led to fractions with increased antiplasmodial activity from which liriodenine (IC50 6.1 ± 0.1 μg/mL, CC50 > 1000.0 μg/mL, SI > 164), an aporphine alkaloid, and an acetogenin-rich fraction containing mainly isomers of annomontacin and 4-deoxy-annomontacin (IC50 22.7 ± 1.9 µg/mL, CC50 336.1 ± 15.5 µg/mL, SI = 15) might be highlighted for their antiplasmodial activity.

Graphical Abstract

Acknowledgments

The authors thank Fundação de Amparo à Pesquisa do Estado de Minas Gerais (FAPEMIG) and Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) for financial support to ABO through PRONEX Rede Malária Processes No. APQ-01129-10 and Process 555655/2009-1, respectively. Also, they thank Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) for PhD scholarship to DCG.

Disclosure statement

The authors confirm that this article content has no conflict of interest.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.